Skip to main content

Daiichi Sankyo Value Stock - Dividend - Research Selection

Daiichi Sankyo Co Ltd

ISIN: JP3475350009, WKN: A0F57T

Market price date: 31.05.2021
Market price: 2.530,00 JPY




Daiichi Sankyo Co Ltd Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 02-05-2021
Cash flow
Net operating cash flow 192.210.000.000
Capital Expenditures -31.245.000.000
Free cash flow 160.965.001.216
Balance sheet
Total Equity 1.272.050.000.000
Liabilities & Shareholders equity 2.085.180.000.000
Income statement
Net income 75.957.000.000
Eps (diluted) 39,110
Diluted shares outstanding 1.940.000.000
Net sales/revenue 962.516.000.000

Fundamental ratios calculated on: 31-05-2021

Ratios
Key figures 31-05-2021
Cash flow
P/C 25,56
   
P/FC 30,49
Balance sheet
ROI3,64
ROE61,00
Income statement
P/E64,69
Div. Yield1,07%
P/B3,86
P/S5,10


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4568.TSE
Market Capitalization47.358.132.224,00 USD
Country
IndicesNIKKEI 225
Sectors
Raw Data SourceIFRS in Millionen JPY
Stock Split2020-09-29,3.000000/1.000000
Internetwww.daiichisankyo.co.jp


Description of the company

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe, China and Brazil markets. As of March 31, 2014, it had 100 subsidiaries and four associated companies.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.daiichisankyo.co.jp